Rchr
J-GLOBAL ID：202301013316524802
Update date: Jun. 02, 2024
Tabata Koshiro
タバタ コウシロウ | Tabata Koshiro
Affiliation and department：
Job title：
Specially Appointed Assistant Professor
Research field (1)：
Virology
Research theme for competitive and other funds (2)：
- 2023 - 2025 IgA抗体を用いた経鼻噴霧型ワクチンの新規DDS基盤技術の開発
- 2020 - 2023 Establishment of a novel serum diagnosis method for flaviviruses based on binding profiles of anti-flavivirus antibodies
Papers (23)：
-
Takuma Ariizumi, Koshiro Tabata, Yukari Itakura, Hiroko Kobayashi, William W Hall, Michihito Sasaki, Hirofumi Sawa, Keita Matsuno, Yasuko Orba. Establishment of a lethal mouse model of emerging tick-borne orthonairovirus infections. PLoS pathogens. 2024. 20. 3. e1012101
-
Michihito Sasaki, Tatsuki Sugi, Shun Iida, Yuichiro Hirata, Shinji Kusakabe, Kei Konishi, Yukari Itakura, Koshiro Tabata, Mai Kishimoto, Hiroko Kobayashi, et al. Combination therapy with oral antiviral and anti-inflammatory drugs improves the efficacy of delayed treatment in a COVID-19 hamster model. EBioMedicine. 2023. 99. 104950-104950
-
Kentaro Uemura, Haruaki Nobori, Akihiko Sato, Shinsuke Toba, Shinji Kusakabe, Michihito Sasaki, Koshiro Tabata, Keita Matsuno, Naoyoshi Maeda, Shiori Ito, et al. 2-thiouridine is a broad-spectrum antiviral nucleoside analogue against positive-strand RNA viruses. Proceedings of the National Academy of Sciences of the United States of America. 2023. 120. 42. e2304139120
-
Koshiro Tabata, Yukari Itakura, Takuma Ariizumi, Manabu Igarashi, Hiroko Kobayashi, Kittiya Intaruck, Mai Kishimoto, Shintaro Kobayashi, William W Hall, Michihito Sasaki, et al. Development of flavivirus subviral particles with low cross-reactivity by mutations of a distinct antigenic domain. Applied microbiology and biotechnology. 2023
-
Shigeru Fujita, Keiya Uriu, Lin Pan, Naganori Nao, Koshiro Tabata, Mai Kishimoto, Yukari Itakura, Hirofumi Sawa, Izumi Kida, Tomokazu Tamura, et al. Impact of imprinted immunity induced by mRNA vaccination in an experimental animal model. The Journal of infectious diseases. 2023
ｍore...
MISC (1)：
-
佐々木道仁, 杉達紀, 飯田俊, 平田雄一郎, 日下部伸治, 日下部伸治, 小西慧, 小西慧, 板倉友香里, 板倉友香里, et al. Combination therapy with oral antiviral and anti-inflammatory treatments improves the delayed-therapeutic effect on COVID-19. 日本ウイルス学会学術集会プログラム・予稿集(Web). 2023. 70th
Education (3)：
- 2019 - 2023 Hokkaido University Graduate School of Infectious Diseases
- 2017 - 2019 Tokyo University of Science Graduate School of Pharmaceutical Sciences
- 2013 - 2017 Tokyo University of Science Faculty of Pharmaceutical Sciences Department of Medicinal and Life Science
Professional career (2)：
- Ph.D. (Veterinary Medicine) (Hokkaido University)
- M.S. (Tokyo University of Science)
Work history (2)：
- 2023/04 - 現在 Hokkaido University Institute for Vaccine Research and Development Specially Appointed Professor
- 2020/04 - 2023/03 日本学術振興会 特別研究員(DC1)
Awards (1)：
- 2023/12 - 日本抗体学会 ポスター発表優秀賞
Return to Previous Page
